can we target aml with car t-cells?
Published 7 years ago • 509 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
2:23
an update on car-t therapy in aml: challenges & emerging strategies
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
1:30
insights into nkg2d-targeting car-t cells in r/r aml
-
1:44
challenges in developing car-t therapy for aml
-
1:16
hurdles to car-t therapy for mds & aml: t-cell fitness & lack of a uniform target antigen
-
2:03
engineering multi-antigenic car t-cells for aml
-
3:07
finding the right targets for car t-cell therapy in aml
-
2:08
challenges with car-t therapy in aml & insights into if-better-gated car-t cells
-
4:43
immunotherapy & car t cells: part 1
-
9:39
what are dual car-t cells?
-
2:30
new leukemia treatment gives hope to cancer sufferers
-
2:11
future prospects for car-t cell therapy in aml
-
3:39
car t-cells and crispr: the future of aml treatment
-
3:33
allogeneic cd123-targeting car t-cell for aml: risks and potential
-
1:41
finding the right targets for car t-cell therapy in aml
-
1:13
the challenges in treating aml with car t-cell therapy
-
3:06
car-t and bites – which targets belong in clinical practice?
-
1:13
challenges of dual-targeted car t-cell therapy
-
0:44
the future for car t-cells in treating aml
-
1:20
new strategies in aml: checkpoint inhibitors combined with t-cell engagers
-
0:52
the future of car t-cell therapy for aml
-
2:54
car t-cell therapy for aml